Literature DB >> 20736237

MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression.

Ana Chinchilla1, Estefania Lozano, Houria Daimi, Francisco J Esteban, Colin Crist, Amelia E Aranega, Diego Franco.   

Abstract

AIMS: non-coding RNA has been recently demonstrated to be a novel mechanism for modulation of gene expression at the post-transcriptional level. The importance of microRNAs in the cardiovascular system is now apparent. Mutations of distinct microRNAs have provided evidence for fundamental roles of microRNAs during cardiovascular development. However, there is limited information about global microRNA profiles during mouse heart development. In this study, we have gained insight from the expression profiles of microRNAs during mouse ventricular development by microarray and qRT-PCR analysis. METHODS AND
RESULTS: our microarray analysis reveals that relatively few microRNAs display either increasing or decreasing expression profiles during ventricular chamber formation. Interestingly, most of the differentially expressed microRNAs display a rather discrete peak of expression at particular developmental stages. Furthermore, we demonstrate that microRNA-27b (miR-27b) displays an overt myocardial expression during heart development and that the transcription factor-encoding gene Mef2c is an miR-27b target.
CONCLUSION: our data present a comprehensive profile of microRNA expression during ventricular maturation, providing an entry point for investigation of the functional roles of the most abundantly and differentially expressed microRNAs during cardiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736237     DOI: 10.1093/cvr/cvq264

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  49 in total

Review 1.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

2.  Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells.

Authors:  Kumar U Kotlo; Bahar Hesabi; Robert S Danziger
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-06       Impact factor: 4.249

3.  Serum MicroRNA-27b as a Screening Biomarker for Left Ventricular Hypertrophy.

Authors:  Yan Wang; Shuyan Chen; Yanhong Gao; Song Zhang
Journal:  Tex Heart Inst J       Date:  2017-12-19

4.  E2F and microRNA regulation of angiogenesis.

Authors:  Dauren Biyashev; Gangjian Qin
Journal:  Am J Cardiovasc Dis       Date:  2011

5.  Up-regulation of miR-27 extenuates lipopolysaccharide-induced injury in H9c2 cells via modulating ICAM1 expression.

Authors:  Jing-Fang Xiang; Jian-Chun Yu; Jian-You Zhu
Journal:  Genes Genomics       Date:  2019-10-01       Impact factor: 1.839

6.  Atrial overexpression of microRNA-27b attenuates angiotensin II-induced atrial fibrosis and fibrillation by targeting ALK5.

Authors:  Yanshan Wang; Heng Cai; Hongmei Li; Zhisheng Gao; Kunqing Song
Journal:  Hum Cell       Date:  2018-04-18       Impact factor: 4.174

Review 7.  Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction.

Authors:  Chuanwei Li; Fang Pei; Xiaoshan Zhu; Dayue D Duan; Chunyu Zeng
Journal:  Clin Biochem       Date:  2012-07       Impact factor: 3.281

Review 8.  Functions of microRNAs in cardiovascular biology and disease.

Authors:  Akiko Hata
Journal:  Annu Rev Physiol       Date:  2012-11-13       Impact factor: 19.318

9.  ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages.

Authors:  Yi-Chien Lu; Sung-Hee Chang; Markus Hafner; Xi Li; Thomas Tuschl; Olivier Elemento; Timothy Hla
Journal:  Cell Rep       Date:  2014-12-18       Impact factor: 9.423

10.  RNA-binding protein AUF1 promotes myogenesis by regulating MEF2C expression levels.

Authors:  Amaresh C Panda; Kotb Abdelmohsen; Je-Hyun Yoon; Jennifer L Martindale; Xiaoling Yang; Jessica Curtis; Evi M Mercken; Devon M Chenette; Yongqing Zhang; Robert J Schneider; Kevin G Becker; Rafael de Cabo; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2014-06-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.